Bruker Return on Investment 2010-2024 | BRKR
Current and historical return on investment (ROI) values for Bruker (BRKR) over the last 10 years.
| Bruker ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2024-12-31 |
$0.25B |
$3.86B |
6.89% |
| 2024-09-30 |
$0.29B |
$4.09B |
8.52% |
| 2024-06-30 |
$0.34B |
$3.94B |
11.75% |
| 2024-03-31 |
$0.38B |
$2.79B |
15.09% |
| 2023-12-31 |
$0.44B |
$2.56B |
18.28% |
| 2023-09-30 |
$0.46B |
$2.33B |
19.89% |
| 2023-06-30 |
$0.47B |
$2.37B |
20.72% |
| 2023-03-31 |
$0.46B |
$2.31B |
20.69% |
| 2022-12-31 |
$0.43B |
$2.33B |
19.68% |
| 2022-09-30 |
$0.43B |
$2.09B |
19.45% |
| 2022-06-30 |
$0.41B |
$2.16B |
19.24% |
| 2022-03-31 |
$0.42B |
$2.24B |
20.82% |
| 2021-12-31 |
$0.41B |
$2.31B |
21.89% |
| 2021-09-30 |
$0.40B |
$1.81B |
22.72% |
| 2021-06-30 |
$0.37B |
$1.74B |
20.96% |
| 2021-03-31 |
$0.32B |
$1.70B |
17.99% |
| 2020-12-31 |
$0.25B |
$1.82B |
13.63% |
| 2020-09-30 |
$0.25B |
$1.79B |
14.07% |
| 2020-06-30 |
$0.26B |
$1.83B |
15.36% |
| 2020-03-31 |
$0.28B |
$1.84B |
17.51% |
| 2019-12-31 |
$0.30B |
$1.73B |
21.12% |
| 2019-09-30 |
$0.29B |
$1.37B |
22.23% |
| 2019-06-30 |
$0.27B |
$1.36B |
22.14% |
| 2019-03-31 |
$0.27B |
$1.25B |
23.52% |
| 2018-12-31 |
$0.26B |
$1.23B |
24.57% |
| 2018-09-30 |
$0.25B |
$1.05B |
23.98% |
| 2018-06-30 |
$0.23B |
$0.99B |
21.40% |
| 2018-03-31 |
$0.22B |
$1.00B |
19.21% |
| 2017-12-31 |
$0.22B |
$1.15B |
18.72% |
| 2017-09-30 |
$0.21B |
$1.22B |
17.85% |
| 2017-06-30 |
$0.20B |
$1.19B |
18.10% |
| 2017-03-31 |
$0.19B |
$1.12B |
17.55% |
| 2016-12-31 |
$0.18B |
$1.09B |
17.69% |
| 2016-09-30 |
$0.17B |
$1.05B |
16.98% |
| 2016-06-30 |
$0.15B |
$0.99B |
15.33% |
| 2016-03-31 |
$0.17B |
$0.99B |
16.47% |
| 2015-12-31 |
$0.15B |
$1.00B |
14.27% |
| 2015-09-30 |
$0.12B |
$1.01B |
11.37% |
| 2015-06-30 |
$0.10B |
$1.01B |
8.86% |
| 2015-03-31 |
$0.10B |
$1.08B |
8.68% |
| 2014-12-31 |
$0.11B |
$1.13B |
8.92% |
| 2014-09-30 |
$0.12B |
$1.17B |
10.09% |
| 2014-06-30 |
$0.15B |
$1.24B |
12.41% |
| 2014-03-31 |
$0.16B |
$1.22B |
13.68% |
| 2013-12-31 |
$0.15B |
$1.21B |
13.47% |
| 2013-09-30 |
$0.13B |
$1.14B |
11.91% |
| 2013-06-30 |
$0.16B |
$1.06B |
15.03% |
| 2013-03-31 |
$0.13B |
$1.03B |
13.46% |
| 2012-12-31 |
$0.16B |
$1.05B |
16.19% |
| 2012-09-30 |
$0.17B |
$0.99B |
18.74% |
| 2012-06-30 |
$0.15B |
$0.89B |
18.06% |
| 2012-03-31 |
$0.17B |
$0.91B |
21.40% |
| 2011-12-31 |
$0.16B |
$0.84B |
22.19% |
| 2011-09-30 |
$0.16B |
$0.64B |
23.85% |
| 2011-06-30 |
$0.16B |
$0.69B |
24.53% |
| 2011-03-31 |
$0.16B |
$0.65B |
26.19% |
| 2010-12-31 |
$0.16B |
$0.61B |
27.81% |
| 2010-09-30 |
$0.18B |
$0.59B |
33.26% |
| 2010-06-30 |
$0.17B |
$0.51B |
32.25% |
| 2010-03-31 |
$0.15B |
$0.53B |
29.49% |
| 2009-12-31 |
$0.14B |
$0.54B |
27.70% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Scientific Instruments Manufacturing |
$6.171B |
$3.366B |
|
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
|
